Is DiaSorin S.p.A. a good investment? DiaSorin S.p.A. (DIAS.VI) is currently trading at 77.04 EUR.
In terms of valuation, the stock trades at a P/E ratio of 28.32. This valuation is generally in line with the broader market.
For income investors, DiaSorin S.p.A. pays a dividend yield of 1.73%. With a payout ratio of 48%, the dividend appears sustainable.
Yes, it pays an annual dividend of 1.30 EUR (1.73% yield).
DiaSorin S.p.A. is classified as a Stock. You can compare it against 7 other assets in the "Related Symbols" list on this page.
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
| Year | Total Dividends |
|---|---|
| ▸2027 |
1.36 EUR
|
| May 21, 2027 (estimated) | 1.3620 |
| ▸2026 |
1.30 EUR
|
| May 18, 2026 | 1.3000 |
| ▸2025 |
1.20 EUR
|
| May 19, 2025 | 1.2000 |
| ▸2024 |
1.15 EUR
|
| May 20, 2024 | 1.1500 |
| ▸2023 |
1.10 EUR
|
| May 22, 2023 | 1.1000 |
| ▸2022 |
1.05 EUR
|
| May 23, 2022 | 1.0500 |
| ▸2021 |
1.00 EUR
|
| May 21, 2021 | 1.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| DiaSorin S.p.A. | May 18, 2026 | Paid | 1.3 EUR |
Community Discussion